Vanguard Group Inc Pliant Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
148Shares Held
63.8MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$60.5 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$49 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$41.6 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$37.2 Million4.12% of portfolio
-
Laurion Capital Management LP New York, NY3.47MShares$36.6 Million0.45% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $512M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...